Klp Kapitalforvaltning As Biotechnology

Klp Kapitalforvaltning As

$20.6 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ETNB 89bio, Inc.	$508M	$111,000 0.0% of portfolio	14,600	Q4 2024 New
PHVS Pharvaris N.V.	$603M	$111,000 0.0% of portfolio	5,800	Q4 2024 New
PLRX Pliant Therapeutics, Inc.	$149M	$107,000 0.0% of portfolio	8,200	Q4 2024 New
RLAY Relay Therapeutics, Inc.	$450M	$101,000 0.0% of portfolio	24,700	Q4 2024 New
VERV Verve Therapeutics, Inc.	$478M	$100,000 0.0% of portfolio	17,900	Q4 2024 New
HUMA Humacyte, Inc.	$425M	$98,000 0.0% of portfolio	19,600	Q4 2024 New
ANNX Annexon, Inc.	$151M	$97,000 0.0% of portfolio	19,100	Q4 2024 New
CAPR Capricor Therapeutics, Inc.	$326M	$91,000 0.0% of portfolio	6,600	Q4 2024 New
KROS Keros Therapeutics, Inc.	$270M	$90,000 0.0% of portfolio	5,700	Q4 2024 New
COGT Cogent Biosciences, Inc.	$576M	$88,000 0.0% of portfolio	11,300	Q4 2024 New
ABUS Arbutus Biopharma Corp	$499M	$83,000 0.0% of portfolio	25,600	Q4 2024 New
CGEM Cullinan Oncology, Inc.	$461M	$82,000 0.0% of portfolio	6,800	Q4 2024 New
ALT Altimmune, Inc.	$324M	$81,000 0.0% of portfolio	11,300	Q4 2024 New
PHAT Phathom Pharmaceuticals, Inc.	$212M	$73,000 0.0% of portfolio	9,100	Q4 2024 New
IMNM Immunome Inc.	$123M	$72,000 0.0% of portfolio	7,100	Q4 2024 New
ARCT Arcturus Therapeutics Holdings Inc.	$428M	$71,000 0.0% of portfolio	4,200	Q4 2024 New
ERAS Erasca, Inc.	$200M	$68,000 0.0% of portfolio	27,400	Q4 2024 New
TBPH Theravance Biopharma, Inc.	$609M	$68,000 0.0% of portfolio	7,300	Q4 2024 New
RVNC Revance Therapeutics, Inc.	$212M	$62,000 0.0% of portfolio	24,400	Q4 2024 New
STOK Stoke Therapeutics, Inc.	$405M	$62,000 0.0% of portfolio	5,700	Q4 2024 New
EYPT Eye Point Pharmaceuticals, Inc.	$214M	$58,000 0.0% of portfolio	7,900	Q4 2024 New
URGN Uro Gen Pharma Ltd.	$241M	$58,000 0.0% of portfolio	5,500	Q4 2024 New
IBRX Immunity Bio, Inc.	$1.36B	$56,000 0.0% of portfolio	22,100	Q4 2024 New
RGNX Regenxbio Inc.	$341M	$54,000 0.0% of portfolio	7,000	Q4 2024 New
ORIC Oric Pharmaceuticals, Inc.	$380M	$50,000 0.0% of portfolio	6,200	Q4 2024 New
SAGE Sage Therapeutics, Inc.	$431M	$48,000 0.0% of portfolio	9,000	Q4 2024 New
FDMT 4 D Molecular Therapeutics, Inc.	$172M	$47,000 0.0% of portfolio	8,600	Q4 2024 New
YMAB Y M Abs Therapeutics, Inc.	$269M	$46,000 0.0% of portfolio	5,900	Q4 2024 New
ALLO Allogene Therapeutics, Inc.	$213M	$43,000 0.0% of portfolio	20,400	Q4 2024 New
ATXS Astria Therapeutics, Inc.	$103M	$40,000 0.0% of portfolio	4,600	Q4 2024 New
SVRA Savara Inc	$310M	$40,000 0.0% of portfolio	13,200	Q4 2024 New
SANA Sana Biotechnology, Inc.	$521M	$39,000 0.0% of portfolio	24,200	Q4 2024 New
TRDA Entrada Therapeutics, Inc.	$384M	$36,000 0.0% of portfolio	2,100	Q4 2024 New
TYRA Tyra Biosciences, Inc.	$520M	$30,000 0.0% of portfolio	2,200	Q4 2024 New
OLMA Olema Pharmaceuticals, Inc.	$204M	$29,000 0.0% of portfolio	5,100	Q4 2024 New
SAVA Cassava Sciences Inc	$93M	$19,000 0.0% of portfolio	8,100	Q4 2024 New
LXRX Lexicon Pharmaceuticals, Inc.	$142M	$19,000 0.0% of portfolio	26,200	Q4 2024 New
TNGX Tango Therapeutics, Inc.	$240M	$19,000 0.0% of portfolio	6,300	Q4 2024 New
ALEC Alector, Inc.	$136M	$16,000 0.0% of portfolio	8,500	Q4 2024 New
APLT Applied Therapeutics Inc.	$27.9M	$12,000 0.0% of portfolio	15,100	Q4 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	6,900	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klp Kapitalforvaltning As, based on Form 13F filings with the SEC.

News

Stay updated on Klp Kapitalforvaltning As with notifications on news.